S8E28: Adenomas and Pituitary Neuroendocrine Tumors

<p>The ongoing debates and nomenclature change and reclassification are apparently over, and adenomas and now referred to as Pit-Net's (pituitary neuroendocrine tumors).  Is this good, bad, or indifferent?  These are complicated matters, so to shed some more light on the subject, we've invited some experts to discuss them.   In today's live talk, I'm joined by co-host and PWN cofounder<a href='https://ccpd.ucsf.edu/team/lewis-blevins-md'> Dr. Lewis Blevins;</a> as you all know, Dr. Blevins is the Medical Director of the California Center for Pituitary disorders at UCSF. Also with us is<a href='https://ccpd.ucsf.edu/team/manish-k-aghi-md-phd'> Dr. Manish Aghi</a>.  Dr. Aghi is a frequent contributor to PWN and an attending Neurosurgeon California Center for Pituitary Disorders. Professor of Neurological Surgery and Principal Investigator, UCSF Brain Tumor Research Center’’  We are also delighted to welcome<a href='https://www.ucsfhealth.org/providers/dr-arie-perry'> Dr. Arie Perry.</a> Dr. Perry is the director of neuropathology at UCSF; he specializes in diagnosing benign and cancerous nervous system tumors, including those of the brain, spinal cord, and peripheral nerves. He is also a specialist in classifying the molecular genetics of tumors, which can be used to help determine the best treatment.  To learn more, <a href='https://pituitaryworldnews.org/adenomas-or-pitnets-a-pituitary-world-news-opinion-editorial/'>this PWN article</a> provides additional background and reading on the subject.</p> <p> </p>